India - Healthcare, Regulatory and Reimbursement Landscape

GlobalData
179 Pages - GLDATA71651
$1,995.00

Summary

GlobalData, the industry analysis specialist, has released its latest report: “India - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Indian pharmaceutical market was worth $13.56B in 2013, which increased to $20.03B in 2019 at a CAGR of 6.57%. The market value is expected to increase further to $29.34B by 2025. In 2020, India was ranked third globally for drug production by volume and 14th by value. It is the largest provider of generic medicines, with a 20% share of global supply by volume. In terms of vaccine production, India meets 62% of the global demand. The growth of the pharmaceutical market is attributed to the innovation and R&D, medical tourism, increased pharmaceutical export, infrastructure development, strong drug manufacturing, and strong domestic demand.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in India, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analysis of the major players in the pharmaceutical market: Sun Pharma, Aurobindo Pharma, Dr. Reddy's Laboratories, GSK, and Novartis
- Profiles and SWOT analysis of the major players in the medical device market: GE Healthcare, Siemens Healthineers, DePuy Synthes, Olympus, and Poly Medicure
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the India healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving India’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact India’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

'

Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Indian Healthcare Market
2.3 Key Highlights: Healthcare Startups in India
2.4 Key Events: Indian Healthcare Timeline, 2015-2021
2.5 Key Events: Indian Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, India, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, India
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, India
3.7 COVID-19 Epidemiology, India
3.8 COVID-19 Impact and Developments in the Healthcare Market, India
3.9 COVID-19 Clinical Trials Landscape, India
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, India, 2019-2021
6.2 Deal Analysis: Medical Device Market, India, 2019-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, India
7.2 HealthTech Deals Landscape, India
7.3 Key HealthTech Deals, India
7.4 Adoption of Technology in Healthcare, India
7.5 Key Developments: Digital Applications for Dealing with the COVID-19 Crisis, India
7.6 Regulatory Scenario Covering Use of Technology in Healthcare, India
7.7 HealthTech Landscape: Benefits and Risks, India
8. Market Access
8.1 Overview of Healthcare System, India
8.2 Reimbursement Process, India
8.3 Overview of Insurance Providers, India
8.4 Healthcare Spending and Medicine Price Index, India
8.5 Pricing Policies, India
8.6 Regulatory Landscape, India
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, India
8.6.3 Market Authorization for Medical Devices, India
8.6.4 Market Authorization for Biosimilars, India
8.6.5 Intellectual Property Rights, Patent, India
8.6.6 Intellectual Property Rights, Trademark, India
8.6.7 Clinical Trial Regulation Process, India
8.6.8 Pharmaceutical Clinical Trials Landscape, India
8.6.9 Medical Devices Clinical Trials Landscape, India
8.6.10 Pharmaceutical Export and Import, India
8.6.11 Pharmaceutical Advertisement Regulations, India
8.6.12 Pharmacy Regulations, India
8.6.13 Labeling and Packaging Regulations, India
9. Country Healthcare Landscape
9.1 Indian Healthcare Policy Highlights
9.2 Healthcare Facilities, India
9.3 Healthcare Parameters, India
9.4 Life Expectancy and Immunization Rate, India
9.5 Environmental Health, India
9.6 Healthcare Personnel, India
9.7 Disease Burden, India
9.8 Healthcare Expenditure, India
10 Trade Associations, India
11 Trade Fairs, India
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List of Tables
Table 1: Approved Biosimilars, India, 2014-2020
Table 2: Top Five Therapeutic Areas by Annual Turnover ($B), India, 2018
Table 3: COVID-19 Indicators (Number of Cases), Global and India, 2021
Table 4: COVID-19 Vaccines Development Landscape, India, 2020-2021
Table 5: Supply of COVID-19 Vaccine to Neighbouring Countries, India, 2021
Table 6: Growth in the Medical Device Manufacturing After COVID-19 Outbreak, India, 2020
Table 7: COVID-19 IVD Products (May ‘20- January ‘21), India, 2020-2021
Table 8: Medical Device Market, India, Major Segments ($B), 2020
Table 9: Diagnostic Imaging Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 10: General Surgery Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 11: Orthopedic Devices Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: Cardiovascular Devices Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 13: Wound Care Management Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 14: Number of Persons Covered under Health Insurance, India, 2017-2018
Table 15: CGHS Contribution, India, 2021
Table 16: ECHS Contribution, India, 2021
Table 17: COVID-19 Health Insurance, India, 2021
Table 18: Legal Provisions for Permission to Import/Manufacture New Drugs, India, 2021
Table 19: Fees for the New Drugs Licensing, India, 2021
Table 20: Consequences of Medical Device (Amendment) Rules 2020, India, 2021
Table 21: Fees for the Medical Device Licensing, India, 2021
Table 22: Patent Fees, India, 2021
Table 23: Trademark Fees, India, 2021
Table 24: Fees for the Clinical Trial of New Drugs, India, 2021
Table 25: Fees for the Import of Drugs, India, 2021List of Figures
Figure 1: Pharmaceutical Market, India, Revenue ($B), 2013-2020
Figure 2: Medical Device Market, India, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in India, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: Deal Overview by Region, 2019-2020
Figure 6: Country Profile, India, 2020
Figure 7: Pharmaceutical Market, India, Revenue ($B), 2013-2020
Figure 8: Pharmaceutical Market, India, Revenue Forecast ($B), 2021-2025
Figure 9: Pharmaceutical Clusters, India, 2021
Figure 10: Pharmaceutical Exports ($B), India, 2012-2019
Figure 11: Top Export Partners, India, 2019
Figure 12: Pharmaceutical Imports ($B), India, 2012-2019
Figure 13: Top Import Partners, India, 2019
Figure 14: Pharmaceutical Supply Channel, India, 2021
Figure 15: Number of Biologics and Biosimilars Approved, India, 2014-2019
Figure 16: OTC Market, India, Revenue ($B), 2013-2020
Figure 17: OTC Market by Drug Category, India, Revenue ($M), 2020
Figure 18: Top Five Therapeutic Areas by Annual Turnover ($B), India, 2018
Figure 19: COVID-19 Cases, India, 2020-2021
Figure 20: COVID-19 Deaths, India, 2020-2021
Figure 21: Vaccine Cold Chain Distribution Network, India, 2021
Figure 22: COVID-19 Vaccination Comparison, Number of Days, India, 2020-2021
Figure 23: COVID-19 Vaccination Progress, Million Population, India, 2021
Figure 24: Supply of COVID-19 Vaccine to Neighbouring Countries, India, 2021
Figure 25: COVID-19 Clinical Trials Count By Trial Status, India, 2020-2021
Figure 26: COVID-19 Clinical Trials Count By Phase, India, 2020-2021
Figure 27: Top Five COVID-19 Clinical Trials Sponsors By Count, India, 2020-2021
Figure 28: Medical Device Market, India, Revenue ($B), 2015-2020
Figure 29: Medical Device Market, India, Revenue Forecast ($B), 2021-2025
Figure 30: Medical Devices Manufacturing Clusters, India, 2020
Figure 31: Medical Device Market, India, Major Segments (%), 2020
Figure 32: Diagnostic Imaging Market, India, Revenue ($B), 2017-2025
Figure 33: Diagnostic Imaging Market, India, Market Share of Major Players (%), 2019
Figure 34: General Surgery Market, India, Revenue ($B), 2017-2025
Figure 35: General Surgery Market, India, Market Share of Major Players (%), 2019
Figure 36: Orthopedic Devices Market, India, Revenue ($B), 2017-2025
Figure 37: Orthopedic Devices Market, India, Market Share of Major Players (%), 2019
Figure 38: Cardiovascular Devices Market, India, Revenue ($B), 2017-2025
Figure 39: Cardiovascular Devices Market, India, Market Share of Major Players (%), 2019
Figure 40: Wound Care Management Market, India, Revenue ($B), 2017-2025
Figure 41: Wound Care Management Market, India, Market Share of Major Players (%), 2019
Figure 42: Diagnostic Market, India, Revenue ($B), 2015-2020
Figure 43: Diagnostic Market, India, Revenue Forecast ($B), 2021-2025
Figure 44: Medical Devices Market, Revenue ($B) of Major Companies, India, 2019
Figure 45: Deal Value and Deal Count, Pharmaceutical Market, India, 2019-2021
Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, India, 2019-2021
Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, India, 2019-2021
Figure 48: Top Five Therapy Areas by Deal Value and Deal Count, Pharmaceutical Market, India, 2019-2021
Figure 49: M&A Deals by Therapy Area, Pharmaceutical Market, India, 2019-2021 (by Value ($M) and by Number)
Figure 50: PE Deals by Therapy Area, Pharmaceutical Market, India, 2019-2021 (by Value ($M) and by Number)
Figure 51: VC Deals by Therapy Area, Pharmaceutical Market, India, 2019-2021 (by Value ($M) and by Number)
Figure 52: Medical Devices Market Deals by Deal Value ($M), India, 2019-2021
Figure 53: Medical Devices Market Deals by Deal Count, India, 2019-2021
Figure 54: Medical Devices Market Deals Share by Deal Value, India, 2019-2021
Figure 55: Medical Devices Market Deals Share by Deal Count, India, 2019-2021
Figure 56: Top Therapy Area by Deal Value and Deal Count, Medical Devices Market, India, 2019-2021

$1,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports